NEW YORK CITY, NY--(MARKET WIRE)--Jul 25, 2007 -- The Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Dementias invite scientists from the biotechnology industry and academia worldwide to apply for a new collaborative research grant award entitled Frontotemporal Dementia Drug Discovery Program. The goal of the program is to catalyze and fund the discovery and development of effective therapies for frontotemporal dementia (FTD).
